G01N 33/5038
Involving detection of metabolites per se
Official title: {involving detection of metabolites per se}
G01N33/5038 (Involving detection of metabolites per se) appears on 219 US grants and 438 published applications in this corpus.
Search patents in G01N- Granted patents
- 219
- Published applications
- 438
- Assignees
- 283
- Inventors
- 1,022
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 4 | 0 |
| 2002 | 4 | 7 |
| 2003 | 3 | 9 |
| 2004 | 1 | 12 |
| 2005 | 3 | 16 |
| 2006 | 3 | 23 |
| 2007 | 1 | 17 |
| 2008 | 8 | 7 |
| 2009 | 8 | 22 |
| 2010 | 10 | 15 |
| 2011 | 9 | 12 |
| 2012 | 7 | 13 |
| 2013 | 11 | 10 |
| 2014 | 12 | 23 |
| 2015 | 11 | 28 |
| 2016 | 11 | 17 |
| 2017 | 14 | 21 |
| 2018 | 10 | 27 |
| 2019 | 10 | 22 |
| 2020 | 13 | 20 |
| 2021 | 11 | 21 |
| 2022 | 15 | 30 |
| 2023 | 7 | 20 |
| 2024 | 10 | 17 |
| 2025 | 10 | 18 |
| 2026 | 6 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for detecting and treating Parkinson's disease comprising sebum biomarkers15 Sep 2026US 12,736,525 B2The University of Manchester
- Gravity flow micro-physiological article and determining a physiological response to a drug8 Sep 2026US 12,728,415 B2Government of the United States of America, AS Represented By the Secretary of Commerce
- Methods and systems for determining metabolic poise and capacity of living cells11 Aug 2026US 12,704,502 B2Agilent Technologies, Inc.
- Genetically modified mice having a humanized programmed cell death 1 gene14 Jul 2026US 12,677,813 B2Regeneron Pharmaceuticals, Inc.
- Stem cell-derived Schwann cells19 May 2026US 12,630,801 B2Memorial Sloan Kettering Cancer Center
- Potency assay matrix for neuronal cells24 Sep 2026US 2026/0287576 A1Aspen Neuroscience, Inc.
- Applications of hepatocyte co-culture system24 Sep 2026US 2026/0287577 A1LifeNet Health
- Genetically encoded reporter expression systems and methods of making and using same18 Jun 2026US 2026/0168988 A1Duke University
- New lactic acid bacteria7 May 2026US 2026/0125635 A1International N&H Denmark Aps
- Compositions and methods targeting swip-10 and mblac1 for the therapeutic modulation of copper dyshomeostasis23 Apr 2026US 2026/0110682 A1
Most cited
By later US patents
- Vascularized perfused microtissue/micro-organ arrays324US 6,197,575 B1Massachusetts Institute of Technology · 2001
- Fourier transform mass spectrometry of complex biological samples70US 6,680,203 B2Esperion Therapeutics, Inc. · 2004
- Methods for drug discovery, disease treatment, and diagnosis using metabolomics45US 7,329,489 B2Cornell Research Foundation, Inc. · 2008
- Process for the measurement of the potency of glatiramer acetate30US 7,429,374 B2Teva Pharmaceutical Industries Ltd. · 2008
- Non nucleoside reverse transcriptase inhibitors29US 7,462,608 B2Gilead Sciences, Inc. · 2008